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Abstract
Serotonin (5-HT) contributes to the prenatal development of the central nervous system, acting as
a morphogen in the young embryo and later as a neurotransmitter. This biologically active agent
influences both morphological and biochemical differentiation of raphe neurons, which give rise to
the descending serotonergic paths that regulate the processing of acutely evoked nociceptive
inputs. The involvement of 5-HT in the prenatal development of tonic nociceptive system has not
been studied. In the present study we evaluated the effects of a single injection (400 mg/kg, 2 ml,
i.p.) of the 5-HT synthesis inhibitor, para-chlorophenylalanine (pCPA), given to pregnant rats during
the critical period fetal serotonin development. The functional integrity of the tonic nociceptive
response was investigated in 25 day old rats using the classic formalin test. Morphological analysis
of brain structures involved in formalin-induced pain and 5-HT levels in the heads of 12-day
embryos were also evaluated. Embryonic levels of 5-HT were significantly lowered by the
treatment. The juvenile rats from pCPA-treated females showed altered brain morphology and cell
differentiation in the developing cortex, hippocampus, raphe nuclei, and substantia nigra. In the
formalin test, there were significant decreases in the intensity and duration of the second phase of
the formalin-induced response, characterizing persistent, tonic pain. The extent of impairments in
the brain structures correlated positively with the level of decrease in the behavioral responses.
The data demonstrate the involvement of 5-HT in the prenatal development of the tonic
nociceptive system. The decreased tonic component of the behavioral response can be explained
by lower activity of the descending excitatory serotonergic system originating in the raphe nuclei,
resulting in decreased tonic pain processing organized at the level of the dorsal horn of the spinal
cord.
Background
Serotonin (5-HT) plays an important role in regulating
the development of the central nervous system [1–4].
Deficiency of 5-HT in early embryogenesis, when this bio-
logically active substance influences cell and tissue devel-
opment, causes disorders in neurogenesis [5,6] and
abnormalities of development of brain and its transmitter
systems. Consequences of these abnormalities persist into
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postnatal life and are accompanied by a number of func-
tional disorders [6]. The involvement of 5-HT in the pre-
natal development of the processes that mediate tonic
nociception remains to be understood. To understand the
role of 5-HT in the development of pain processing, we
decreased 5-HT content in fetal brain during the period
when there is active development of nociceptive systems.
In the present research, we focused our attention on inves-
tigation of the tonic component of nociceptive system in
the juvenile (25-day-olds) offspring of rats born to
females, who during a critical period of development of
fetal serotonergic development were treated with an
inhibitor of 5-HT synthesis, para-chlorophenylalanine
(pCPA). We were particularly interested in the functional
abnormalities of nociception in the behavioral response
in the widely used formalin test [7] and in morphological
characteristics of brain structures involved that response.
The behavioral response to injection of formalin is pre-
sented by two phases. The first, short, acute phase reflects
acute pain and the second, prolonged, tonic phase – tonic
pain. Between the phases, there is an interphase, a period
of inactivity, characterizing a process of inhibition in the
central nervous system [10]. At 25 days of age rat pups the
biphasic behavioral response in the formalin test has
matured [8,9]. The formalin test, unlike other tests that
are usually used for nociception estimation, favors studies
of the feedback-type modulation effects and endogenous
systems of pain regulation, including the descending ser-
otonergic system.
Material and Methods
Rats
Experiments were performed in 25-day-old rat pups (30
females, 35 males) that were the offspring of 18 female
Wistar rats. The guidelines published by the Committee
for Research and Ethical Issues of the IASP on ethical
standards for investigations of experimental pain in ani-
mals were followed [11]. Adult female and male rats
obtained from the vivarium of I.P. Pavlov Institute of
Physiology, were placed together in plastic cages (55 × 35
× 20 cm) for a night in our laboratory vivarium. Next
morning vaginal smears were used to determine preg-
nancy. The presence of sperm was declared gestational day
0 (GD0). The day of birth of offspring was defined as post-
natal day 0 (P0). Two days after birth each litter was culled
to eight pups, four females and four males. Each litter was
housed in a plastic cage and kept in the temperature-con-
trolled laboratory vivarium (20–22°C) with a 12 h light/
12 h dark cycle beginning at 07:00 h, and with full access
to food and water.
5-HT depletion
5-HT depletion was performed by injection of an aqueous
suspension of the inhibitor of 5-HT synthesis, pCPA (400
mg/kg/2 ml, i.p.; ICN, U.S.A.), to the dams on day 9 of
pregnancy. The day of injection was selected because the
maximal effect of the drug (the greatest decrease of 5-HT
concentration in the dam and in the embryo) is within 2–
3 days after injection at this age. This developmental win-
dow is critical for development of the serotonergic system,
since it is this time when dorsal raphe neurons start to dif-
ferentiate [5,12]. The dose of pCPA was chosen because it
had been reported that 5-HT concentration in rat's mid-
brain was decreased by 74% three days after comparable
treatment [13]. To confirm the effect of maternal pCPA
treatment on 5-HT concentration in heads of 12-day-old
embryos, the females were anesthetized with ether, the
fetuses were removed and females sacrificed. Embryos
were placed into a petri dish with ice-cold phosphate buff-
ered saline and the heads were cut off at the neck under
control of bifocal microscope. The heads were placed into
liquid nitrogen and kept at 70°C for no more than a week.
Concentration of 5-HT was determined using high-per-
formance liquid chromatography (HPLC) and was
expressed as ng per mg of protein estimated by Lowry
method [14]. The Biochemistry Laboratory of the Institute
of Obstetrics and Gynecology (ST. Petersburg) performed
these analyses.
The formalin test
At 25 days of age each rat pup was weighed and then
placed into an experimental chamber (25 × 25 × 25 cm)
with transparent walls for recording specific behaviors –
flexing, shaking and licking – in response to formalin
injection (2.5%, 10 µl into the plantar pad of the left
hindpaw). We recorded the intensity of behaviors during
each minute for 60 min, which is the duration of the
response. We analyzed both the intensity (the number of
flexes+shakes and licking duration in sec) and duration
(in min) of the first and the second phase response and
the duration of the interphase. These responses character-
ize pain sensitivity in the formalin test [7]. Control rat
pups (7 females and 7 males) were injected with the saline
of equivalent volume into the pad of the left hind paw.
Morphological analysis
Morphological analysis of the brain was carried out using
routine histological techniques. The brain was fixed in the
Bouin fixative, embedded in paraffin and frontal sections
7 µm thick were prepared. The sections were stained for
Nissl substance.
Statistical analysis
Statistical analysis used the Wilcoxon rank pair test for
comparison within each group, for dependent variables
(along with Student's t-test for dependent variables) and
the Mann-Whitney test for evaluation of different groups
of animals, for independent variables. Non-parametric
tests were used because scores were not normallyReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/96
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distributed. For all tests P < 0.05 was considered as statis-
tically significant.
Results
In the 25-day-old offspring of saline-treated female con-
trols, the injection of formalin induced the biphasic
behavioral response consisting of the first phase (1–4
min) and the second phase (12–24 min). The interphase
between them lasted for 6–9 min during which the spe-
cific behaviors, flexing, shaking or licking, were not
shown. Similar injection of saline to 25-day-old offspring
from both pCPA- and saline-treated females did not pro-
duce any nociceptive behaviors.
The birth weights of pups from pCPA-treated females were
somewhat lower than those of control pups, but during
the postnatal development the weights of rat pups in both
groups were equal (58.5 ± 0.9 g in 25-day-old rat pups
from pCPA-treated females and 59.4 ± 1.1 g from saline-
treated controls).
The treatment of rats with pCPA on day 9 of pregnancy led
to significant changes in formalin-induced pain in their
25-day-old offspring and severe morphological altera-
tions in brain structures involved in formalin-induced
pain, compared to offspring from control females. Bio-
chemical assays indicated that the levels of 5-HT content
in heads of 12-day-old fetus from pCPA-treated females
were 63,6% lower compared to those in control fetuses
and were 0,05 ± 0,006 ng/mg (n = 5) and 0,137 ± 0,01 ng/
mg (n = 6), respectively.
Of all prenatally pCPA-treated animals 12 of 14 female rat
pups and 10 of 15 male rat pups showed reliable
decreases in pain sensitivity during the second phase. The
remainder of pups prenatally treated with pCPA (2
females and 5 males) failed to show any nociceptive spe-
cific behaviors in response to injection of formalin and
therefore were not included in Figures 1 and 2 or the anal-
yses. The reduction in nociception was evidenced by a sig-
nificant decrease in number of flexes+shakes (p < 0.05;
Fig. 1, Aa) and licking duration (p < 0.04; Fig. 1, Ba) in
female pups and by a significant decrease (p < 0,02) of
flexing+shaking behavior (Fig. 1, Ab) and a pronounced
tendency for a decrease of licking duration (Fig. 1, Bb) in
male pups, compared appropriate controls. Moreover,
pCPA treatment of the pregnant rats compared to saline
treatment produced in offspring a highly significant
decrease in duration of the second phase of the response
to formalin, both in female pups (flexing+shaking, p <
0.006, Fig. 2 Aa; licking p < 0.002, Fig. 2 Ba) and male
pups (flexing+shaking, p < 0.02, Fig. 2, Ab; licking, p <
0.01, Fig. 2, Bb). Duration of the interphase increased (p
< 0.02) in prenatally pCPA-treated female rat pups com-
pared to prenatally saline-treated female pups (Fig. 2, Aa).
No differences were found between female and male rat
pups in the behavioral response in the formalin test.
Figures 3 and 4 demonstrate the most typical morpholog-
ical changes in the brain structures observed following
prenatal pCPA treatment in rat pups that failed to show
any behavioral response in the formalin test. Morpholog-
ical analysis of the neocortex, hippocampus and raphe
nuclei demonstrated that prenatally pCPA-exposed ani-
mals had a fully layered cortex but with reduced cortical
thickness and fewer cells. The neurons of the neocortex
had large round and very faintly stained nuclei with a thin
rim of cytoplasm and little Nissl substance (Fig. 3). Hyper-
chromatosis-like loss of either single neurons or neuron
clusters was found in all the layers of the cingular, occipi-
tal and parietal cortex and the substantia nigra. Chroma-
tolysis was observed often in the upper cortical layers;
shrunken cells were demonstrated in periamygdalar area
and in the prepyriform cortex. Neurons in the CA4 zone
of the hippocampus were inappropriately oriented and
there were fewer cells in the raphe nuclei than in the con-
trol. Morphological characteristics of neurons in the raphe
nuclei were similar to those found in neocortex (Fig. 4). In
animals with decreased behavioral response the morpho-
logical changes were similar but less pronounced.
Discussion
The present study demonstrated that a single pCPA treat-
ment of rats on day 9 of pregnancy, a critical day for the
normal fetal development of serotonin, resulted in altera-
tions of brain morphology and tonic nociception in 25-
day-old offspring. Moreover, the study provides evidence
for a significant decrease in the level of 5-HT content in
heads of 12-day-old embryos from pCPA-treated com-
pared to saline-treated females. These results are consist-
ent with the data that maternal pCPA treatment
significantly depleted 5-HT levels within embryonic 5-HT
neurons [15].
A comparative qualitative analysis of the state of neurons
in brain structures (the cortical areas, hippocampus, raphe
nuclei, substantia nigra) of rat pups from pCPA-treated
females, revealed essential disorders in neuronal develop-
ment and differentiation. These findings are noteworthy
because of the lack of data on mechanisms of formalin-
induced pain other than for spinal cord and brain stem.
It is important to note that the morphological damage
described in our study in offspring from pCPA-treated
females was accompanied by decreased nociceptive sensi-
tivity during the second phase of behavioral response: the
significant decrease in flexing/ shaking and licking behav-
iors organized at the spinal and supraspinal levels, respec-
tively. Some rat pups from pCPA-treated females showed
a total suppression of the behavioral responses. TheReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/96
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formalin test gives an opportunity to assess quantitatively
nociceptive sensitivity [7]. The second phase of biphasic
behavioral response in the formalin test characterizes
tonic pain and is determined by both central and periph-
eral sensitization, induced by the first phase and by affer-
ent signaling from the inflammation focus [16,17]. The
differences in the effects of prenatal 5-HT depletion on the
indices of the first and second phases are attributable to
the different neurophysiologic and neurochemical mech-
anisms mediating tonic and acute nociception [18,19].
Furthermore, in contrast to acute pain, which serves a pro-
tective function, tonic pain is associated with inflamma-
tion and is under prolonged control of the hypothalamic-
pituitary-adrenal system, which is influenced by 5-HT
[20]. Prenatal 5-HT depletion alters 5-HT-hormonal inter-
actions, which in turn might alter tonic pain. The
increased interphase duration in the female rat pups sug-
gests increased inhibition in the central nervous system
The effect of pCPA treatment of the pregnant rats on intensity of the biphasic behavioral response in the formalin test in 25- day-old offspring Figure 1
The effect of pCPA treatment of the pregnant rats on intensity of the biphasic behavioral response in the formalin test in 25-
day-old offspring. A, The number of flexes+shakes; B, licking duration (sec); a, female, b, male rat pups. P1, P2, the first and 
second phases, respectively. The data are shown as the mean ± SEM. Asterisks indicate statistically significant differences 
between offspring of pCPA- and saline-treated (control) rats.
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and is consistent with data showing that descending 5-HT
raphe inputs slow the maturation of inhibitory systems in
the spinal cord [21].
Our observations demonstrated that rat pups with total
suppression of the behavioral response displayed more
pronounced morphological impairments in cortical struc-
tures, hippocampus, raphe nuclei, substantia nigra than
compared to those with decreased response. These struc-
tures are thought to be involved in the biphasic response
to formalin [22,23] and receive projections from the sero-
tonergic centers – the dorsal and medial raphe nuclei [24].
The effect of pCPA treatment of the pregnant rats on the duration of the phases and the interphase of the behavioral response  in the formalin test in 25-day-old offspring Figure 2
The effect of pCPA treatment of the pregnant rats on the duration of the phases and the interphase of the behavioral response 
in the formalin test in 25-day-old offspring. A, The duration (min) of the phases and the interphase in flexing+shaking behaviors. 
B, The duration (min) of the phases and the interphase in licking behavior. a, female, b, male rat pups. P1, P2, the first and sec-
ond phase, respectively. IntP, the interphase. The data are shown as the mean ± SEM. Asterisks indicate statistically significant 
differences between offspring of pCPA- and saline-treated (control) rats.
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The individual differences in the behavioral responses and
concomitant morphological alterations in brain structures
in rat pups even from the same litter may be accounted for
by the fact that ovulation and fertilization of eggs in
females do not occur simultaneously. For this reason, the
embryos located in the uterus at the moment of injection
Cells of neocortex (the 5th layer) in 25-day-old rat pup Figure 3
Cells of neocortex (the 5th layer) in 25-day-old rat pup. Nissl staining. Magnification, X400; a – prenatally saline-treated (con-
trol), b – pCPA-treated rat pups, pCPA was injected at a dose of 400 mg/kg, 2 ml, intraperitoneally to the female rat on day 9 
of pregnancy. Note the evident cell loss and morphological alterations of neurons, that have large round and very light nuclei 
with a thin rim of cytoplasm with little Nissl' substance in a prenatally pCPA-treated rat pup as compared with control.
Cells of the dorsal raphe nuclei in 25-day-old rat pup Figure 4
Cells of the dorsal raphe nuclei in 25-day-old rat pup. Nissl staining. Magnification, X400; a – a prenatally saline-treated (con-
trol), b – a pCPA-treated rat pup, pCPA was injected at a dose of 400 mg/kg, 2 ml, intraperitoneally to the female rat on day 9 
of pregnancy. Note the evident cell loss and morphological alterations of neurons, that have large round and very light nuclei 
with a thin rim of cytoplasm with little Nissl' substance in a prenatally pCPA-treated rat pup as compared with control.
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are at different stages of embryonic development [25].
Moreover, individual differences in pharmacokinetics
may have also played a role.
The current studies are consistent with altered develop-
ment of descending serotonergic pathways and 5-HT3
receptors [27]. The 5-HT3 receptors have been located
both in brain and on primary sensory fibers in the dorsal
horn [28]. There is a conclusive proof that 5-HT released
from the descending bulbospinal neurons exerts a dual
influence on spinal nociceptive transmission: facilitation
through the 5-HT3 receptor and inhibition through the 5-
HT1A receptor [29]. Furthermore, Green and Dickenson
[26] reported that the descending serotonergic system is
enhanced during formalin-induced inflammation, acting
via excitatory 5-HT3 receptors in the dorsal horn of the
spinal cord, thus, facilitating the response of nociceptive
spinal neurons to peripheral irritant. Antagonists of 5-
HT3 receptors, blocking the actions of 5-HT in the spinal
cord, are antinociceptive [7]. The present data suggest that
abnormal development of the dorsal raphe nuclei and
other brain structures under study may impair the func-
tion of the descending excitatory serotonergic system. As a
result, the nociceptive signals entering the supraspinal
structures are inhibited, with a consequent decrease in the
behavioral indices of the second phase in formalin-
induced pain. The above-mentioned facts and our find-
ings are consistent with the hypothesis that the activity of
5-HT3 receptors in rat pups after prenatal 5-HT depletion
is strongly suppressed.
In summary, our study shows that a single pCPA treat-
ment of the pregnant rat during the critical period of early
development of the serotonergic system in the fetus leads
to the decrease in the level of 5-HT content in fetus brains,
and morphological alterations in developing cortical
areas, hippocampus, raphe nuclei and substantia nigra,
involved in formalin-induced pain. These impairments
are accompanied by a severe loss of pain sensitivity during
the second phase of the behavioral response in 25-day-old
offspring. The data obtained demonstrate the involve-
ment of 5-HT in the prenatal development of the tonic
nociceptive system assessed in the formalin test in juve-
nile rats.
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